November 2019 Monthly Update
Rights Issue – Lodgement of Offer Information Statement
Special General Meeting Results
Rights Issue – Book Closure Date Announcement
Agrifood Fund Agreement Signed
Q3 2019 Earnings Press Release
Rights Issue – Additional Listing Application
September 2019 Monthly Update
Response to SGX Queries on Proposed Rights Issue
Rights Issue Announcement
Trendlines Announces Investment Commitments in Agrifood Fund
August 2019 Monthly Update
Incorporation of Nasotrak Medical as Subsidiary
ApiFix Receives FDA Approval
Incorporation of Szone Medical as Subsidiary
Changes/Disclosure of Interest of Substantial Shareholders
Q2 2019 Earnings Press Release
Q2 2019 Unaudited Financial Statements
Completion of Placement
July 2019 Monthly Update
Listing & Quotation Notice on Placement
Trendlines and Librae Sign SGD10.88 Million Investment Agreement
Trendlines and Librae Sign Placement Proposal Agreement
Trendlines Secures Commitment for New Fund
Bayer Trendlines Ag Innovation Fund Makes Second Investment
June 2019 Monthly Update
5 Portfolio Companies Awarded Horizon 2020 Grants
May 2019 Monthly Update
Q1 2019 Earnings Press Release
Q1 2019 Unaudited Financial Results
April 2019 Monthly Update
Annual General Meeting Results and Presentation
Dividend Distribution to Stimatix Shareholders
Correction to Annual Report FY2018
March 2019 Monthly Update
Stimatix Product Website Launch
Notice of AGM
Annual Report Print Request Form
February 2019 Monthly Update
Incorporation of Subsidiairies
Grant of Options
FY 2018 Earnings Press Release
FY 2018 Unaudited Financial Results
Special General Meeting Results & Presentation
Leviticus Cardio Announces Successful FIH
January 2019 Monthly Update
Management Changes to Strengthen and Accelerate Investment Activities
Appointment of Nir Goldenberg as CEO Trendlines Labs
Cessation of Yosef Hazan as CEO Trendlines Labs
Appointment of Barak Singer as CEO Trendlines Incubators Israel
Cessation of Nitza Kardish PhD as CEO Trendlines Incubators Israel
Trendlines Medical Singapore Delivers Partnership Outcomes
Incorporation of Portfolio Companies Considered Subsidiaries
SEEDS Capital Names Trendlines Co-Investment Partner
Special General Meeting
December 2018 Monthly Update
Trendlines to Launch Agrifood Tech Center in Singapore
November 2018 Monthly Update
Grant of Options
Trendlines Medical Singapore and A*ccelerate Partner
Q3 2018 Earnings Press Release
Q3 2018 Unaudited Financial Results
October 2018 Monthly Update
September 2018 Monthly Update
August 2018 Monthly Update
Cessation of Company’s VP Business Development
Q2 2018 Earnings Press Release
Q2 Unaudited Financial Statements
July 2018 Monthly Update
Termination of Term Sheet and Joint Venture Agreement
OrthoSpin Announces US$3 Million Investment from J&J
Haim Brosh Named CFO
Appointment of Haim Brosh as CFO, Joint Company Secretary and Compliance Officer
ViAqua Therapeutics Completes Investment from Nutreco
June 2018 Monthly Update
Arcuro Medical Announces FDA Clearance
Press Release on Management Changes
Cessation of CFO and Joint Company Secretary and appointment of interim CFO
Announcement of Cessation of CFO and Joint Company Secretary
May 2018 Monthly Update
Trendlines and Sirius VC Sign Co-investment Agreement
Q1 2018 Earnings Press Release
Q1 2018 Unaudited Financial Statements
April 2018 Monthly Update
Special General Meeting Results
Annual General Meeting Results and Presentation
BioFishency Significantly Increases Sales in 2018
Trendlines Discloses 2014 Asset Purchase Agreement Details
March 2018 Monthly Update
Trendlines and Nutreco Sign Collaboration MOU
Notice of Special General Meeting and Circular to Shareholders
Notice of Annual General Meeting
February 2018 Monthly Update
Saturas Completes US$4 Million Investment Round
FY2017 Earnings Press Release
FY2017 Unaudited Financial Statements
Trendlines Medical Singapore Selected for Startup SG Equity Program
January 2018 Monthly Update
STS Medical Receives FDA Clearance
ApiFix Announces Management Changes
December 2017 Monthly Update
Magdent Completes Raise
November 2017 Monthly Update
AquiNovo Raises US$1.5 Million
National Healthcare Group and Trendlines Enter into MOU
Trendlines Exits MitrAssist
Consummation of MitrAssist Exit
Cessation of COO and Joint Company Secretary
Q3 2017 Earnings Press Release
Q3 2017 Unaudited Financial Results
Purchase of Shares by Directors
October 2017 Monthly Update
Strategic Review and Expenses Reduction Plan
Dividend Policy
Response to SGX Queries Re Trading Activity
Change of % Interest of Substantial Shareholders
Trendlines Raises S$14 Million in Share Placement
Completion of Proposed S$14 Million Placement
Proposed Placement
September 2017 Monthly Update
Trendlines Singapore Medical Makes First Investment
Incorporation of Portfolio Company as Subsidiary
Placement Announcement
Purchase of Shares by Directors
Vensica Medical Receives US$2 Million Investment
Fidmi Medical Raises US$2 Million
Trendlines and Haier Sign MOU
EdenShield Raises US$2 Million
Purchase of Shares by Directors
August 2017 Monthly Update
Sale of Holdings in Mitrassist
Press Release on Trendlines-Shoushan Wealth Joint Venture Agreement
Signing of Joint Venture Agreement Trendlines Shoushan Wealth
Purchase of Shares by Directors
Q2 2017 Earnings Press Release and FAQs
July 2017 Monthly Update
ApiFix Closes Spanish Distribution Deal with Acuna-Fombona
Purchase of Shares by Directors
Trendlines Report: 10 Companies to Watch
June 2017 Monthly Update
Bayer Trendlines Ag Innovation Fund Makes First Investment
Trendlines Completes Sale of BioSight
Consummation of BioSight Exit
Most Valuable Company’s Product on Schedule
June Purchase of Shares by Directors
May 2017 Monthly Update
Trendlines Exits BioSight
Trendlines Exits BioSight Ltd.
Q1 2017 Earnings Press Release
Q1 2017 Unaudited Financial Statements
Purchase of Shares by Directors – May
Q1 Earnings Conference Call
April 2017 Monthly Update
Special General Meeting March 2017 Results
Annual General Meeting March 2017 Results
Information on AGM and SGM Agenda
Purchase of Shares by Directors – April
Grant of Options
March 2017 Monthly Update
Trendlines Labs Receives Grant from SIIRD for Clinical Trials in Singapore
Notice of Special General Meeting and Circular to Shareholders
Notice of Annual General Meeting
Purchase of Shares by Directors – March
February 2017 Monthly Update
Grant of Waiver
Opening of Trendlines Medical Singapore
FY2016 Press Release
Trendlines Celebrates Ten Years
Purchase of Shares by Directors February
January Monthly Update
The Trendlines Group to Present at Noble Capital Markets 13th Annual Investor Conference
Trendlines Medical Singapore Receives S$2.2 Million Grant from SPRING Singapore
Trendlines Medical Singapore Receives S$2.2 Million Grant from SPRING Singapore
Purchase of Shares by Directors/Chief Executive Officers
December 2016 Monthly Update
PrimePartners Corporate Finance Holdings Invests in Trendlines Medical
Execution of Share Purchase Agreement
Completion of Allotment and Issuance of Shares by Trendlines Medical Singapore
One-Year Post-IPO Presentation
B. Braun Melsungen AG Invests in Trendlines Medical Singapore
Definitive Agreement between B. Braun Melsungen AG and Trendlines Medical Singapore
Venture Capital Fund and China Joint Venture
Disclosure of Changes in Interests of Directors
Gordian Surgical Completes Raise and Receives FDA
Trendlines November 2016 Update
B. Braun / Trendlines Partnership Leads to ApiFix Investment
Change of Subsidiary Name
Q3 2016 Earnings Call Press Release
Q3 2016 Unaudited Financial Results
Invitation to Q3 2016 Results Conference Call
Notification of Q3 2016 Results Conference Call
October 2016 Update
Approval of Trendlines Medical Mandate Expansion
Trendlines Completes Successful Sale of E.T.View Medical
Trendlines September 2016 Monthly Update
Disclosure of Interests
E.T. VIew Medical Concludes Merger with Ambu A/S
Announcement of Appointment – Dr Nitza Kardish
Announcement of Transition – Dr. Eran Feldhay
Trendlines Grant of Options
B.Braun Investment in Trendlines Medical Singapore
Clarification on Purchase of Shares by Chairmen
Trendlines August 2016 Update
Trendlines Commences ADR Trading on OTCQX
Purchase of Company Shares by Chairmen
Disclosure of Directors’ Interests
Grant of Options Pursuant to Trendlines 2015 Share Option Plan
Q2 2016 Press Release & Presentation
Invitation to Q2 Results Conference Call
Trendlines July 2016 Update
Establishment of Trendlines Medical Singapore
Trendlines June 2016 Update
Special General Meeting Announcement and Circular
Definitive Agreement on Sale of E.T.View
Expansion of Trendlines Medical OCS Mandate
Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer
Trendlines Negotiations Towards Sale of E.T.View
Trendlines May 2016 Update
Trendlines Launches ADR Program
Q1 2016 Financial Results Press Release
Trendlines April 2016 Update
Annual General Meeting Results
Bayer Trendlines Ag Innovation Fund
Trendlines March 2016 Update
Annual Report FY2015
Trendlines Clarification to Business Times Article
Results of Incubator Tender March 2016
Announcement of Appointment – Moshe Katzenelson
Trendlines Investor Presentation March 2016
Trendlines Financial Highlights Updated March 2016
AGM Notice
Definitive Collaboration Agreement with B.Braun
February 2016 Update
Additional Purchase Order from U.S. based Medical Device Public Company
Trendlines Investor Presentation February 2016
Special General Meeting Results Feb 2016
Financial Highlights 2015-2016 Presentation
Press Release Financial Results
Trendlines FY2015 Unaudited Results Announcement
Clarification to a Publication by The Straits Times
Trendlines Signs Agreement with Japanese Medical Company
Trendlines January Update
Special General Meeting and Circular to Shareholders
2015 Trendlines Highlights
Trendlines Negotiates MOU with MNC
Trendlines Investor Presentation January 2016
Allotment and Issuance of Shares
Trendlines Grant of Options
Trendlines Agtech Submits Tender Bid
The Trendlines Group Establishes Two New Companies
Trendlines Medical Renews Incubator Franchise
Saviva Capital LLC Commits To Participate in Trendlines Bid for Israel Government Incubator Franchise, Invest US$9.2 Million
Trading Debut for Trendlines as the 100th Listing on Catalist
Successful Completion of The Trendlines Group Ltd.’s IPO with Strong Investor Interest, S$25.0 Million Total Proceeds Raised
Prospectus
